Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI

aDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; bCardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; cFrankel Cardiovascular Center, University of Michigan, Ann Arbor, MI; dNuclear Medicine and Diagnostic Imaging Section, Division of Human Health, International Atomic Energy Agency, Vienna, Austria; eAtrius Health, Somerville, MA; fNational Heart Centre, Singapore, Singapore; gSaint Luke’s Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO; hHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX; iDepartments of Nuclear Medicine and Cardiovascular Imaging, Diagnostico Maipu, Department of Nuclear Medicine, Instituto Argentino de Diagnostico y Tratamiento, Buenos Aires, Argentina; jUniversitat Autonoma de Barcelona, Barcelona, Spain; kDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada; lOhioHealth Heart and Vascular Physicians, Columbus, OH; mDepartment of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD; nFondazione Toscana Gabriele Monasterio, Pisa, Italy; oDepartment of Radiology, Duke University Health System, Durham, NC; pDivision of Cardiology, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA; and qDepartment of Medicine, Cardiology Division, and Department of Radiology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY